Profile
Reinilde Heyrman is currently Chief Medical Officer at Medpace Holdings, Inc. since 2017.
Former positions include Chief Clinical Development Officer at Ikaria, Inc. and Secretary, Chief Clinical Development Officer & VP at Bellerophon Therapeutics, Inc. Education includes a doctorate from the University of Antwerp.
Reinilde Heyrman active positions
| Companies | Position | Start |
|---|---|---|
| MEDPACE HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2017-08-31 |
Former positions of Reinilde Heyrman
| Companies | Position | End |
|---|---|---|
| IKARIA, INC. | Corporate Officer/Principal | - |
| BELLEROPHON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Reinilde Heyrman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Ikaria, Inc.
Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
Bellerophon Therapeutics, Inc.
Bellerophon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products to treat cardiopulmonary diseases | Health Technology |
University of Antwerp
University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medpace Holdings, Inc.
Medpace Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a a clinical contract research organization company which provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries | Commercial Services |
- Stock Market
- Insiders
- Reinilde Heyrman
















